Results 211 to 220 of about 394,438 (273)
Using a 3D tumor microenvironment (TME)‐on‐a‐chip model, tumor–stromal–immune crosstalk in triple‐negative breast cancer is studied, revealing the TME's combinatorial effect on cancer progression. Integrating single‐cell transcriptomic analysis demonstrates metabolic reprogramming via the kynurenine pathway, highlighting the complex TME cellular ...
Kalpana Ravi+7 more
wiley +1 more source
Two-plex <i>in vivo</i> molecular imaging in the second near-infrared window for immunotherapeutic response. [PDF]
Sun Y+13 more
europepmc +1 more source
Selective depletion of CD8+ T lymphocytes for prevention of graft- versus-host disease after allogeneic bone marrow transplantation [PDF]
Richard E. Champlin+9 more
openalex +1 more source
Single‐Cell Atlas Reveals Tumorigenic Profiles and Immune Dynamics of Adrenal Incidentalomas
Single‐cell RNA sequencing reveals cellular heterogeneity in adrenal incidentalomas, identifying distinct tumor cell populations. Clusterin is recognized as a biomarker for adrenocortical tumors, correlating with established markers. MYCN‐positive clusters in pheochromocytomas indicated poorer survival.
Meng Wang+18 more
wiley +1 more source
A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland. [PDF]
Besson J+12 more
europepmc +1 more source
CLDN18.2 is a highly selective biomarker exposed in gastric cancer. A CLDN18.2‐specific antibody 1D5 conjugated fluorescence‐magnetic nanoparticle is developed for image‐guided precision theragnostics. Under the assistance of sensitive FMI and deep‐penetrating MPI for tracing and timing the optimal nanoparticle dosage, combining α‐PD1 therapy with ...
Xueying Wang+14 more
wiley +1 more source
Changes in the immune index before and after surgery in urinary malignancy patients with AIDS. [PDF]
Xue W, Zhang Y, Zhang M, Huang Z.
europepmc +1 more source
A tumor‐adhesive chitosan‐derived immune agonist TACTIC is developed for strong and durable anti‐tumor immunity. The immune agonist exhibits multi‐targets and modulates both tumor cell immunogenicity and pro‐inflammatory responses in immune cells, thereby potentiating the therapeutic efficacy of clinical radiotherapy.
Huilan He+8 more
wiley +1 more source
In vivo armed macrophages curb liver metastasis through tumor-reactive T-cell rejuvenation. [PDF]
Notaro M+20 more
europepmc +1 more source